Health Care For Our Bones: A Practical Nutritional Approach to Preventing Osteoporosis
Article Outline
Acknowledgment
References
1.Siris, ES, Miller, PD, Barrett-Connor, E, Faulkner, KG, Wehren, LE, Abbott, TA et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the national osteoporosis risk assessment. J Am Med Assoc. 2001; 286: 2815–2822
2.Hegsted, DM. Fractures, calcium and the modern diet. Am J Clin Nutr. 2001; 74: 571–573
3.Watkins, BA, Lippman, HE, Le Bouteiller, L, Li, Y, and Seifert, MF. Bioactive fatty acids: role in bone biology and bone cell function. Prog Lip Res. 2001; 40: 125–148
4.Tucker, KL, Hannan, MT, Chen, H, Cupples, LA, Wilson, PW, and Kiel, DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr.1999; 69: 727–736
5.New, SA, Robins, SP, Campbell, MK, Martin, JC, Garton, MJ, Bolton-Smith, C et al. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health?. Am J Clin Nutr. 2000; 71: 142–151
6.Sebastian, A, Harris, ST, Ottaway, JH, Todd, KM, and Morris, RC. Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med. 1994; 330: 1776–1781
7.Remer, T. Influence of diet on acid-base balance. Semin Dial. 2000; 13: 221–226
8.Lindh, E, Ljunghall, S, Larsson, K, and Lavo, B. Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med. 1992; 231: 403–406
9.Cordain, L. Cereal grains: humanity’s double edge sword. World Rev Nutr Diet. 1999; 84: 19–73
10.Simopoulos, AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999; 70: 560S–569S
12.Seaman, DR. in: Clinical nutrition for pain, inflammation, and tissue healing. NutrAnalysis, Hendersonville, NC; 1998: 107–109
13.Hands, ES. in: Nutrients in food. Lippincott Williams & Wilkins, Philadelphia, PA; 2000: 1–336
14.Heaney, RP. Protein intake and bone health: the influence of belief systems on the conduct of nutritional science. Am J Clin Nutr. 2001; 73: 5–6
15.Cordain, L, Watkins, BA, Florant, GL, Kelher, M, Rogers, L, and Li, Y. Fatty acid analysis of wild ruminant tissues: evolutionary implications for reducing diet-related chronic disease. Eur J Clin Nutr. 2002; 56: 181–191
16.Ilich, JZ and Kerstetter, JE. Nutrition in bone health revisted: a story beyond calcium. J Am Coll Nutr. 2000; 19:715–737
17.Roubenoff, R and Blumberg, JB. The effects of a multivitamin/mineral supplement on micronutrient status, antioxidant capacity and cytokine production in healthy older adults consuming a fortified diet. J Am Coll Nutr.2000; 19: 613–621
18.McKay, DL, Perrone, G, Rasmussen, H, Dallal, G, and Blumberg, JB. Multivitamin/mineral supplementation improves plasma B-vitamin status and homocysteine concentration in healthy older adults consuming a folate-fortified diet. J Nutr. 2000; 130: 3090–3096
19.Chandra, RK. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects.Nutrition. 2001; 17: 709–712
20.Mares-Perlman, JA, Lyle, BJ, Klein, R, Fishre, AL, Brady, WE, VandenLangenberg, GM et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol. 2000; 118: 1556–1563
21.Schlebusch, L, Bosch, BA, Polglase, G, Kleinschmidt, I, Pillay, BJ, and Cassimjee, MH. A double-blind, placebo-controlled, double-centre study of the effects of an oral multivitamin-mineral combination on stress. S Afr Med J.2000; 90: 1216–1223
22.Fenech, M and Ferguson, LR. Vitamins/minerals and genomic stability in humans. Mutat Res. 2001; 475: 1–6
23.Frank, E, Bendich, A, and Denniston, M. Use of vitamin-mineral supplements by female physicians in the United States. Am J Clin Nutr. 2000; 72: 969–975
24.Simopoulos, AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002; 21:495–505
25.Kremer, JM. N-3 fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr. 2000; 71: 349S–351S
26.Elin, RJ. Magnesium: fifth but forgotten electrolyte. Am J Clin Path. 1994; 102: 616–622
27.Alexandersen, P and Riis, B. Letters to editor. J Am Med Assoc. 2001; 286: 1836–1837
29.Seelig, M. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations-magnesium and chloride loss in refractory potassium repletion. Am J Cardiol. 1989; 63: 4G–21G
30.Durlach, J. Recommended dietary amounts of magnesium: Mg RDA. Mag Res. 1989; 2: 195–203
31.Brandi, ML. Flavonoids: biochemical effects and therapeutic applications. Bone Mineral. 1992; 19: S3–S14
32.Agnusdei, D and Bufalino, L. Efficacy of ipriflavone in established osteoporosis and long-term safety. Calcif Tissue Int. 1997; 61: S23–S32
33.Scheiber, MD and Rebar, RW. Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy?. Menopause. 1999; 6: 233–241
34.Alexandersen, P, Toussaint, A, Christiansen, C, Devogelaer, JP, Roux, C, Fechtenbaum, J et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. J Am Med Assoc. 2001; 285: 1482–1488
35.Beers, MN and Berkow, R. in: The merck manual of diagnosis and therapy. 17th Ed. Merck Research Laboratories, Whitehouse Station, NJ; 1999: 854
36.Pines, A, Raafat, H, Lynn, AH, and Whittington, J. Clinical trial of microcrystalline hydroxyapatite compound (‘Ossopan’) in the prevention of osteoporosis due to corticosteroid therapy. Curr Med Res Opin. 1984; 8: 734–742
37.Stellon, A, Davies, A, Webb, A, and Williams, R. Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis. Postgrad Med J. 1985; 61: 791–796
38.Ruegsegger, P, Keller, A, and Dambacher, MA. Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females. Osteoporosis Int. 1995; 5: 30–34